These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12031)

  • 1. Effect on graft-versus-host response of donor mouse preimmunization with M-locus and DBA/2 (DAG) antigens [proceedings].
    Matossian-Rogers A; Festenstein H
    Folia Biol (Praha); 1976; 22(6):428. PubMed ID: 12031
    [No Abstract]   [Full Text] [Related]  

  • 2. Spleen cell transplantation in mice: influence of non-H-2 M locus on graft-vs.-host and host-vs.-graft reactions.
    Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1373-5. PubMed ID: 4149546
    [No Abstract]   [Full Text] [Related]  

  • 3. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Graft vs host reaction in reciprocal combinations of mouse strains differing by the H-2 complex of histocompatibility].
    Maianskiĭ DN
    Biull Eksp Biol Med; 1976 Aug; 82(8):974-7. PubMed ID: 16675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of host-versus-graft and graft-versus-host reactions on the immune response of mice to sheep red blood cells.
    Zaleski M
    Folia Biol (Praha); 1971; 17(2):111-22. PubMed ID: 4396932
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered host-allograft relationships for mouse tumors modified by prior passage in vitro and in vivo. II. Reactivity of lymphoid cells.
    Jacobs BB
    J Natl Cancer Inst; 1972 Oct; 49(4):1085-91. PubMed ID: 4404346
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 14. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V; Müerköster S; Umansky V
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of alloimmunization on T cells mediating graft-vs-host splenomegaly or the allogeneic effect in F1 mice.
    Morse HC; Pasanen VJ; Asofsky R
    J Immunol; 1977 Feb; 118(2):574-7. PubMed ID: 14212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of weak graft-versus-host reactions by the suppressive effect on the immune response (author's transl)].
    Marchal G
    Ann Immunol (Paris); 1977; 128(6):1085-9. PubMed ID: 23066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responsiveness to MIs locus antigens in graft-versus-host and host-versus-graft reactions.
    Wolters EA; Brons NH; van der Kwast TH; Benner R
    Cell Immunol; 1980 May; 51(2):215-25. PubMed ID: 6445232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.